nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Peritonitis—Paclitaxel—ovarian cancer	0.0465	0.0465	CcSEcCtD
Sevelamer—Intestinal obstruction—Topotecan—ovarian cancer	0.03	0.03	CcSEcCtD
Sevelamer—Intestinal perforation—Paclitaxel—ovarian cancer	0.0297	0.0297	CcSEcCtD
Sevelamer—Intestinal obstruction—Vinorelbine—ovarian cancer	0.0256	0.0256	CcSEcCtD
Sevelamer—Ileus—Vinorelbine—ovarian cancer	0.0247	0.0247	CcSEcCtD
Sevelamer—Faecaloma—Epirubicin—ovarian cancer	0.0235	0.0235	CcSEcCtD
Sevelamer—Faecalith—Epirubicin—ovarian cancer	0.0235	0.0235	CcSEcCtD
Sevelamer—Anorexia—Altretamine—ovarian cancer	0.022	0.022	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—ovarian cancer	0.0218	0.0218	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—ovarian cancer	0.0218	0.0218	CcSEcCtD
Sevelamer—Decreased appetite—Altretamine—ovarian cancer	0.02	0.02	CcSEcCtD
Sevelamer—Fatigue—Altretamine—ovarian cancer	0.0199	0.0199	CcSEcCtD
Sevelamer—Intestinal obstruction—Paclitaxel—ovarian cancer	0.0172	0.0172	CcSEcCtD
Sevelamer—Ileus—Paclitaxel—ovarian cancer	0.0166	0.0166	CcSEcCtD
Sevelamer—Asthenia—Altretamine—ovarian cancer	0.0165	0.0165	CcSEcCtD
Sevelamer—Vomiting—Altretamine—ovarian cancer	0.0146	0.0146	CcSEcCtD
Sevelamer—Intestinal obstruction—Docetaxel—ovarian cancer	0.0146	0.0146	CcSEcCtD
Sevelamer—Ileus—Docetaxel—ovarian cancer	0.0141	0.0141	CcSEcCtD
Sevelamer—Nausea—Altretamine—ovarian cancer	0.0137	0.0137	CcSEcCtD
Sevelamer—Pain—Carboplatin—ovarian cancer	0.0136	0.0136	CcSEcCtD
Sevelamer—Ileus—Epirubicin—ovarian cancer	0.00949	0.00949	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—ovarian cancer	0.00879	0.00879	CcSEcCtD
Sevelamer—Anorexia—Chlorambucil—ovarian cancer	0.0078	0.0078	CcSEcCtD
Sevelamer—Arthralgia—Topotecan—ovarian cancer	0.0076	0.0076	CcSEcCtD
Sevelamer—Abdominal distension—Paclitaxel—ovarian cancer	0.00742	0.00742	CcSEcCtD
Sevelamer—Dyspepsia—Chlorambucil—ovarian cancer	0.00721	0.00721	CcSEcCtD
Sevelamer—Decreased appetite—Chlorambucil—ovarian cancer	0.00712	0.00712	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00707	0.00707	CcSEcCtD
Sevelamer—Fatigue—Chlorambucil—ovarian cancer	0.00706	0.00706	CcSEcCtD
Sevelamer—Pain—Chlorambucil—ovarian cancer	0.007	0.007	CcSEcCtD
Sevelamer—Anorexia—Topotecan—ovarian cancer	0.00695	0.00695	CcSEcCtD
Sevelamer—Anorexia—Melphalan—ovarian cancer	0.0068	0.0068	CcSEcCtD
Sevelamer—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.0067	0.0067	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00664	0.00664	CcSEcCtD
Sevelamer—Arthralgia—Vinorelbine—ovarian cancer	0.0065	0.0065	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.0065	0.0065	CcSEcCtD
Sevelamer—Abdominal pain—Chlorambucil—ovarian cancer	0.00647	0.00647	CcSEcCtD
Sevelamer—Dyspepsia—Topotecan—ovarian cancer	0.00642	0.00642	CcSEcCtD
Sevelamer—Decreased appetite—Topotecan—ovarian cancer	0.00634	0.00634	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00629	0.00629	CcSEcCtD
Sevelamer—Fatigue—Topotecan—ovarian cancer	0.00628	0.00628	CcSEcCtD
Sevelamer—Dyspepsia—Melphalan—ovarian cancer	0.00628	0.00628	CcSEcCtD
Sevelamer—Pain—Topotecan—ovarian cancer	0.00623	0.00623	CcSEcCtD
Sevelamer—Constipation—Topotecan—ovarian cancer	0.00623	0.00623	CcSEcCtD
Sevelamer—Decreased appetite—Melphalan—ovarian cancer	0.0062	0.0062	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00616	0.00616	CcSEcCtD
Sevelamer—Fatigue—Melphalan—ovarian cancer	0.00615	0.00615	CcSEcCtD
Sevelamer—Pain—Melphalan—ovarian cancer	0.0061	0.0061	CcSEcCtD
Sevelamer—Gastrointestinal pain—Topotecan—ovarian cancer	0.00596	0.00596	CcSEcCtD
Sevelamer—Anorexia—Vinorelbine—ovarian cancer	0.00594	0.00594	CcSEcCtD
Sevelamer—Asthenia—Chlorambucil—ovarian cancer	0.00587	0.00587	CcSEcCtD
Sevelamer—Pruritus—Chlorambucil—ovarian cancer	0.00579	0.00579	CcSEcCtD
Sevelamer—Abdominal pain—Topotecan—ovarian cancer	0.00576	0.00576	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00568	0.00568	CcSEcCtD
Sevelamer—Diarrhoea—Chlorambucil—ovarian cancer	0.0056	0.0056	CcSEcCtD
Sevelamer—Decreased appetite—Vinorelbine—ovarian cancer	0.00542	0.00542	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00538	0.00538	CcSEcCtD
Sevelamer—Fatigue—Vinorelbine—ovarian cancer	0.00538	0.00538	CcSEcCtD
Sevelamer—Constipation—Vinorelbine—ovarian cancer	0.00533	0.00533	CcSEcCtD
Sevelamer—Pain—Vinorelbine—ovarian cancer	0.00533	0.00533	CcSEcCtD
Sevelamer—Asthenia—Topotecan—ovarian cancer	0.00523	0.00523	CcSEcCtD
Sevelamer—Vomiting—Chlorambucil—ovarian cancer	0.00521	0.00521	CcSEcCtD
Sevelamer—Pruritus—Topotecan—ovarian cancer	0.00516	0.00516	CcSEcCtD
Sevelamer—Asthenia—Melphalan—ovarian cancer	0.00512	0.00512	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.0051	0.0051	CcSEcCtD
Sevelamer—Flatulence—Paclitaxel—ovarian cancer	0.00506	0.00506	CcSEcCtD
Sevelamer—Pruritus—Melphalan—ovarian cancer	0.00505	0.00505	CcSEcCtD
Sevelamer—Diarrhoea—Topotecan—ovarian cancer	0.00499	0.00499	CcSEcCtD
Sevelamer—Abdominal pain—Vinorelbine—ovarian cancer	0.00493	0.00493	CcSEcCtD
Sevelamer—Diarrhoea—Melphalan—ovarian cancer	0.00488	0.00488	CcSEcCtD
Sevelamer—Nausea—Chlorambucil—ovarian cancer	0.00486	0.00486	CcSEcCtD
Sevelamer—Vomiting—Topotecan—ovarian cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Rash—Topotecan—ovarian cancer	0.0046	0.0046	CcSEcCtD
Sevelamer—Dermatitis—Topotecan—ovarian cancer	0.00459	0.00459	CcSEcCtD
Sevelamer—Vomiting—Melphalan—ovarian cancer	0.00454	0.00454	CcSEcCtD
Sevelamer—Rash—Melphalan—ovarian cancer	0.0045	0.0045	CcSEcCtD
Sevelamer—Dermatitis—Melphalan—ovarian cancer	0.0045	0.0045	CcSEcCtD
Sevelamer—Asthenia—Vinorelbine—ovarian cancer	0.00447	0.00447	CcSEcCtD
Sevelamer—Pruritus—Vinorelbine—ovarian cancer	0.00441	0.00441	CcSEcCtD
Sevelamer—Arthralgia—Paclitaxel—ovarian cancer	0.00437	0.00437	CcSEcCtD
Sevelamer—Nausea—Topotecan—ovarian cancer	0.00433	0.00433	CcSEcCtD
Sevelamer—Diarrhoea—Vinorelbine—ovarian cancer	0.00427	0.00427	CcSEcCtD
Sevelamer—Abdominal distension—Epirubicin—ovarian cancer	0.00424	0.00424	CcSEcCtD
Sevelamer—Nausea—Melphalan—ovarian cancer	0.00424	0.00424	CcSEcCtD
Sevelamer—Anorexia—Paclitaxel—ovarian cancer	0.004	0.004	CcSEcCtD
Sevelamer—Vomiting—Vinorelbine—ovarian cancer	0.00396	0.00396	CcSEcCtD
Sevelamer—Rash—Vinorelbine—ovarian cancer	0.00393	0.00393	CcSEcCtD
Sevelamer—Dermatitis—Vinorelbine—ovarian cancer	0.00393	0.00393	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—ovarian cancer	0.00393	0.00393	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00382	0.00382	CcSEcCtD
Sevelamer—Arthralgia—Docetaxel—ovarian cancer	0.00371	0.00371	CcSEcCtD
Sevelamer—Nausea—Vinorelbine—ovarian cancer	0.0037	0.0037	CcSEcCtD
Sevelamer—Dyspepsia—Paclitaxel—ovarian cancer	0.00369	0.00369	CcSEcCtD
Sevelamer—Decreased appetite—Paclitaxel—ovarian cancer	0.00365	0.00365	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00362	0.00362	CcSEcCtD
Sevelamer—Fatigue—Paclitaxel—ovarian cancer	0.00362	0.00362	CcSEcCtD
Sevelamer—Pain—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Sevelamer—Constipation—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Sevelamer—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00343	0.00343	CcSEcCtD
Sevelamer—Anorexia—Docetaxel—ovarian cancer	0.00339	0.00339	CcSEcCtD
Sevelamer—Abdominal pain—Paclitaxel—ovarian cancer	0.00332	0.00332	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00324	0.00324	CcSEcCtD
Sevelamer—Dyspepsia—Docetaxel—ovarian cancer	0.00313	0.00313	CcSEcCtD
Sevelamer—Decreased appetite—Docetaxel—ovarian cancer	0.00309	0.00309	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00307	0.00307	CcSEcCtD
Sevelamer—Fatigue—Docetaxel—ovarian cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Pain—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Sevelamer—Constipation—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Sevelamer—Asthenia—Paclitaxel—ovarian cancer	0.00301	0.00301	CcSEcCtD
Sevelamer—Pruritus—Paclitaxel—ovarian cancer	0.00297	0.00297	CcSEcCtD
Sevelamer—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Sevelamer—Flatulence—Epirubicin—ovarian cancer	0.00289	0.00289	CcSEcCtD
Sevelamer—Diarrhoea—Paclitaxel—ovarian cancer	0.00287	0.00287	CcSEcCtD
Sevelamer—Abdominal pain—Docetaxel—ovarian cancer	0.00281	0.00281	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—ovarian cancer	0.00268	0.00268	CcSEcCtD
Sevelamer—Vomiting—Paclitaxel—ovarian cancer	0.00267	0.00267	CcSEcCtD
Sevelamer—Rash—Paclitaxel—ovarian cancer	0.00264	0.00264	CcSEcCtD
Sevelamer—Dermatitis—Paclitaxel—ovarian cancer	0.00264	0.00264	CcSEcCtD
Sevelamer—Asthenia—Docetaxel—ovarian cancer	0.00255	0.00255	CcSEcCtD
Sevelamer—Pruritus—Docetaxel—ovarian cancer	0.00251	0.00251	CcSEcCtD
Sevelamer—Arthralgia—Epirubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Sevelamer—Nausea—Paclitaxel—ovarian cancer	0.00249	0.00249	CcSEcCtD
Sevelamer—Diarrhoea—Docetaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—ovarian cancer	0.00231	0.00231	CcSEcCtD
Sevelamer—Anorexia—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Sevelamer—Vomiting—Docetaxel—ovarian cancer	0.00226	0.00226	CcSEcCtD
Sevelamer—Rash—Docetaxel—ovarian cancer	0.00224	0.00224	CcSEcCtD
Sevelamer—Dermatitis—Docetaxel—ovarian cancer	0.00224	0.00224	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00218	0.00218	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—ovarian cancer	0.00211	0.00211	CcSEcCtD
Sevelamer—Nausea—Docetaxel—ovarian cancer	0.00211	0.00211	CcSEcCtD
Sevelamer—Dyspepsia—Epirubicin—ovarian cancer	0.00211	0.00211	CcSEcCtD
Sevelamer—Decreased appetite—Epirubicin—ovarian cancer	0.00208	0.00208	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00207	0.00207	CcSEcCtD
Sevelamer—Fatigue—Epirubicin—ovarian cancer	0.00207	0.00207	CcSEcCtD
Sevelamer—Constipation—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Sevelamer—Pain—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00202	0.00202	CcSEcCtD
Sevelamer—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—ovarian cancer	0.00195	0.00195	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—ovarian cancer	0.00193	0.00193	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00192	0.00192	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—ovarian cancer	0.00191	0.00191	CcSEcCtD
Sevelamer—Pain—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Abdominal pain—Epirubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Sevelamer—Asthenia—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Sevelamer—Pruritus—Epirubicin—ovarian cancer	0.0017	0.0017	CcSEcCtD
Sevelamer—Diarrhoea—Epirubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Sevelamer—Vomiting—Epirubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Rash—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Sevelamer—Dermatitis—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Sevelamer—Nausea—Epirubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Sevelamer—Rash—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
